(lp0
S"Horizon Pharma plc Launches RAREis Campaign Elevating Faces of the Rare ... GlobeNewswire  - Feb 28, 2017 DUBLIN, Ireland, Feb. 28, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p1
aS"Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp. GlobeNewswire  - Oct 25, 2016 DUBLIN, Ireland, Oct. 25, 2016  -- Horizon Pharma plc  a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;...Horizon Pharma  Stock: Spikes On Raptor Acquisition, Fortifies Pipeline ... - CNA Finance "
p2
aS"Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care ... Nasdaq - Feb 14, 2017 DUBLIN, Ireland, Feb. 14, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p3
aS"Horizon Pharma plc Announces Urea Cycle Disorders Medical Foods and ... GlobeNewswire  - Mar 2, 2017 DUBLIN, Ireland, March 02, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p4
aS"Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on ... GlobeNewswire  - Jan 27, 2017 DUBLIN, Ireland, Jan. 27, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p5
aS'Global Genes and Horizon Pharma plc Partner to Offer Nephropathic Cystinosis ... PR Newswire  - Jan 17, 2017 17, 2017 /PRNewswire-USNewswire/ -- Global Genes and Horizon Pharma plc  announced the Horizon Nephropathic Cystinosis Scholarship , an exclusive opportunity for people living with nephropathic cystinosis to further their&nbsp;...Rare Disease College Report: Nephropathic Cystinosis Scholarships Available - Rare Disease Report'
p6
aS"Down 22%, Is Horizon Pharma plc Stock a Bad-News Buy? Motley Fool - Dec 8, 2016 Horizon Pharma's  stock dropped by more than 22% on Thursday after its phase 3 Steadfast trial of Actimmune in Friedreich's Ataxia failed to meet its primary endpoint of improvement on the modified Friedreich's Ataxia Rating Scale&nbsp;...Horizon Pharma aborts key Actimmune trial; shares plunge - Reuters"
p7
aS'Horizon Pharma plc  Moves Higher on Volume Spike for February 24 Equities.com - Feb 24, 2017 Horizon Pharma plc  traded on unusually high volume on Feb. 24, as the stock gained 1.75% to close at $17.45. On the day, Horizon Pharma plc saw 3.91 million shares trade hands on 22,002 trades. Considering that the stock averages only a daily&nbsp;...Earnings Guidance on Horizon Pharma PLC - Energy IndexHorizon Pharma PLC  Receives $30.70 Average Price Target from Brokerages - Chaffey Breeze'
p8
aS'Company Update : Horizon Pharma PLC Announces Availability of ... Smarter Analyst - Dec 22, 2016 Horizon Pharma PLC  and its affiliate Horizon Therapeutics Canada Limited announced that QUINSAIR  is now available in Canada for the management of chronic pulmonary infections due to Pseudomonas&nbsp;...'
p9
aS'Horizon Pharma plc  Moves Lower on Volume Spike for March 07 Equities.com - Mar 7, 2017 Horizon Pharma plc  traded on unusually high volume on Mar. 07, as the stock lost 3.42% to close at $14.97. On the day, Horizon Pharma plc saw 5.56 million shares trade hands on 33,005 trades. Considering that the stock averages only a daily&nbsp;...Horizon Pharma plc  Quarterly EPS At $0.84 - Stock ObserverHorizon Pharma plc  Closed the Last Trading Session with decrease ... - The Newburgh Press'
p10
a.